Video Discussion: Role for molecular markers predicting the best chemotherapy?

Portal Forums Lung/Thoracic Cancer General Lung/Thoracic Cancer Video Discussion: Role for molecular markers predicting the best chemotherapy?

This topic contains 1 reply, has 2 voices, and was last updated by Dr West Dr West 5 years, 1 month ago.

Viewing 2 posts - 1 through 2 (of 2 total)
Author Posts   
Author Posts
June 10, 2013 at 7:01 pm  #1257171    
Denise Brock
Denise Brock

Hello!
A follower on our GRACE facebook page asked a question that perhaps someone here can speak to — her question was in response to today’s recently posted video – http://cancergrace.org/lung/2013/06/10/madeit-sclg-molecular-selection-of-chemo-advanced-nsclc/ - where Drs. Nate Pennell, Mary Pinder, and Jack West discuss trials presented at ASCO 2013 testing the potential value of molecular marker testing to select optimal chemo for advanced non-small cell lung cancer (NSCLC).

Her question was – “Is this similar to what happens at Rational Therapeutics in Long Beach?” If anyone is familiar with this, perhaps they can speak to this. (I have posted a link to this forum in facebook for her to follow up with.)

Thanks!
D


Operations Director for GRACE. I came to GRACE after my best friend was diagnosed with lung cancer. She passed on July 31, 2010; she lives on in her family and friends, and in her beautiful daughter who looks more and more like her every day. If she were still here today, she would be blazing the advocacy trail. All part of her legacy. http://www.facebook.com/deniseabrock http://www.facebook.com/cancerGRACE

June 10, 2013 at 8:26 pm  #1257172    
Dr West
Dr West

So the answer is “yes”, this is very similar to the work done by Rational Therapeutics. They use the same kinds of markers to predict the right chemo, but I’d be very skeptical about all of these approaches when the few trials that have actually tested this directly have proven to be stone cold negative.

-Dr. West

Viewing 2 posts - 1 through 2 (of 2 total)

You must be logged in to reply to this topic.